IL33 and pancreatic ductal adenocarcinoma: Besides, miR-940 can inhibit the growth of pancreatic ductal adenocarcinoma via targeting MyD88 [41] that involved in IL-33 mediated type 1 helper T cells (Th1) differentiation [42] (Th1 is pivotal in cellular immunity).